Alvotech Secures Financing Facilities of Approximately $136 Million
Existing senior bonds upsized by $70 million with additional investment from a consortium of institutional investorsAlvotech acquires the Reykjavik manufacturing facility, previously utilized under a long-term lease agreement, and secures approximately $16 million, at current exchange rates, in gross loan proceeds through refinancing of secured loan facilityAlvotech secures $50 million in financing in the form of an unsecured subordinated loan facility from Alvogen REYKJAVIK, Iceland , Nov. 16, 2022 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced financing f
